According to Oncolytics Biotech 's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -NZ$43.95 Million. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 | -NZ$44.39 Million | 0.99% |
2023 | -NZ$43.95 Million | 23.16% |
2022 | -NZ$35.69 Million | -1.57% |
2021 | -NZ$36.26 Million | 9.3% |
2020 | -NZ$33.17 Million | 22.2% |
2019 | -NZ$27.15 Million | 22.91% |
2018 | -NZ$22.09 Million | 3.98% |
2017 | -NZ$21.24 Million | 4.75% |
2016 | -NZ$20.28 Million | 8.81% |
2015 | -NZ$18.64 Million | -37.12% |
2014 | -NZ$29.64 Million | -26.12% |
2013 | -NZ$40.12 Million | -37.4% |
2012 | -NZ$64.09 Million | 29% |
2011 | -NZ$49.68 Million | 46.18% |
2010 | -NZ$33.99 Million | 35.46% |
2009 | -NZ$25.09 Million | -14.08% |
2008 | -NZ$29.2 Million | -0.52% |
2007 | -NZ$29.35 Million | 24.21% |
2006 | -NZ$23.64 Million | 44.52% |
2005 | -NZ$16.36 Million | -11.17% |
2004 | -NZ$18.41 Million | 115.42% |
2003 | -NZ$8.55 Million | 13.74% |
2002 | -NZ$7.52 Million | -5.45% |
2001 | -NZ$7.95 Million |